Tagged with “sunitinib”
ArchivesPhase III Sutent Trial for Colorectal Cancer Discontinued
Pfizer announced yesterday, June 30, 2009, that they are discontinuing a phase III trial comparing FOLFIRI chemotherapy alone to FOLFIRI with added Sutent® (sunitinib).
Based on results so far, the independent Data Monitoring Committee (DMC) determined that a significant reduction in progression-free survival was not statistically possible. No new safety concerns were identified. Continue reading…
Posted by Kate Murphy on July 1st, 2009
Posted in: Research & Treatment News | No Comments »
Tags: clinical trials, sunitinib, Sutent
Follow @FightCRC on Twitter
Become a Fan on Facebook
